Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES | BSE: 540025

Mid-range Performer

Download real time

308.65 2.70 (0.88%)

45.95% Fall from 52W High

1.1M NSE+BSE Volume

High volume today

NSE 28 May, 2025 3:31 PM (IST)

3,453.2

Market Cap

Above industry Median

0.9

Beta 1Year

Low volatility

Advanced Enzyme Technologies Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Advanced Enzyme Technologies Ltd. from all sources in a single place.

Advanced Enzyme Technologies Ltd.

23 May 2025

308.65

0.88%

Company Update

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Intimation of Analyst / Institutional Investor Meeting with UTI Mutual Fund.

Advanced Enzyme Technologies Ltd.

23 May 2025

308.65

0.88%

Company Update

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Intimation of Analyst / Institutional Investor Meeting with Eternity Capital LLP

Advanced Enzyme Technologies Ltd.

23 May 2025

308.65

0.88%

Company Update

Advanced Enzyme Technologies Ltd - 540025 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Please find attached herewith Annual Secretarial Compliance Report for year ended March 31, 2025.

Advanced Enzyme Technologies Ltd.

19 May 2025

308.65

0.88%

Earnings Call

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

In furtherance to our intimated letter dated May 09, 2025, please find enclosed the Transcript of the Conference call held on Wednesday, May 14, 2025 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31, 2025

Advanced Enzyme Technologies Ltd.

15 May 2025

308.65

0.88%

Company Update

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Intimation of Analyst / Institutional Investor Meeting with CVC Global

Advanced Enzyme Technologies Ltd.

14 May 2025

308.65

0.88%

Earnings Call

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, May 14, 2025 on the audited Financial Results for the quarter and year ended March 31, 2025, is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner

Advanced Enzyme Technologies Ltd.

14 May 2025

308.65

0.88%

Company Update

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed Copy of newspaper publication of Extract of audited Consolidated Financials Results for the quarter and year ended March 31, 2025 publised in The Free Press Journal and Mumbai Lakshadeep on May 14, 2025

Advanced Enzyme Technologies Ltd.

14 May 2025

308.65

0.88%

to see Rapid results content

Advanced Enzyme Technologies Ltd.

13 May 2025

308.65

0.88%

Investor Presentation

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor presentation for quarter and year ended March 31, 2025.

Advanced Enzyme Technologies Ltd.

13 May 2025

308.65

0.88%

Company Update

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release titled Quarterly Earnings Release

Is Advanced Enzyme Technologies Ltd. worth buying?

340 Votes:

Buy 84.12%

Sell 10.88%

Hold 5.0%